Log In
BCIQ
Print this Print this
 

MSPrecise Blood Assay

  Manage Alerts
Collapse Summary General Information
Company Avant Diagnostics Inc.
DescriptionNext-generation DNA sequencing assay that measures mutations found in rearranged immunoglobulin genes in B cells isolated from blood
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPivotal
Standard IndicationNeurology, Diagnostic
Indication DetailsDetermine risk of developing multiple sclerosis (MS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$28.8M

0

$3.2M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/12/2016

$28.8M

0

$3.2M

Get a free BioCentury trial today